Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 12.00% vs 4.34% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -7.73% vs 1,564.29% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 4.89% vs 133.57% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
Compare Quarterly Results Of Aurinia Pharmaceuticals, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 12.00% vs 4.34% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 22.38% vs 37.83% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -7.73% vs 1,564.29% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 2,971.43% vs 106.09% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 4.89% vs 133.57% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 736.59% vs 121.47% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -8.33% vs 1,100.00% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






